About Us
Despite significant efforts, pancreatic cancer continues to present unique challenges, and outcomes for patients have not improved as rapidly as for some other cancers. Similarly, advancements in care for patients with pancreatitis and its long-term effects have not kept pace with breakthroughs in other acute and chronic conditions. At the Brenden-Colson Center, we believe it is time for a new approach to pancreatic disease.
Our Goals
- Improve early detection of pancreatic disease through the development of less invasive tests and innovative imaging techniques.
- Conduct translational research to develop advanced and innovative surgical and medical treatments for both benign and malignant pancreatic diseases.
- Develop and implement effective treatments and programs that enhance the quality of life for patients with pancreatic disease.
- Foster and support scientific discovery to deepen our understanding of pancreatic health and disease.
- Provide comprehensive education for both healthcare providers and patients on the latest advancements in understanding and treating pancreatic disease.
Our Values
- Patients are at the center of everything. All of our research and clinical efforts are focused on improving treatments and care for patients.
- Continual collaboration drives progress. We leverage OHSU’s world-leading expertise in areas such as pancreatic surgery, genomics, and precision medicine. By bringing together a diverse team of experts focused on pancreatic disease, we approach challenges with vigor, cooperation, and passion.
- Translate emerging knowledge into action rapidly. We are committed to rapidly translating emerging knowledge into actionable treatments, ensuring that every patient who comes to us has the opportunity to benefit from the latest discoveries.